JP2003522157A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003522157A5 JP2003522157A5 JP2001557585A JP2001557585A JP2003522157A5 JP 2003522157 A5 JP2003522157 A5 JP 2003522157A5 JP 2001557585 A JP2001557585 A JP 2001557585A JP 2001557585 A JP2001557585 A JP 2001557585A JP 2003522157 A5 JP2003522157 A5 JP 2003522157A5
- Authority
- JP
- Japan
- Prior art keywords
- cell cycle
- regulatory protein
- cycle regulatory
- cancer
- tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101710150974 Regulator of chromosome condensation Proteins 0.000 description 4
- 102100039977 Regulator of chromosome condensation Human genes 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940126074 CDK kinase inhibitor Drugs 0.000 description 1
- 102100034770 Cyclin-dependent kinase inhibitor 3 Human genes 0.000 description 1
- 101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 1
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 description 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10006033.1 | 2000-02-10 | ||
| DE10006033A DE10006033B4 (de) | 2000-02-10 | 2000-02-10 | Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen |
| PCT/DE2001/000470 WO2001058477A2 (de) | 2000-02-10 | 2001-02-07 | Immunisierung eines individuums gegen carcinome und ihre vorstufen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003522157A JP2003522157A (ja) | 2003-07-22 |
| JP2003522157A5 true JP2003522157A5 (enExample) | 2008-03-27 |
| JP4936626B2 JP4936626B2 (ja) | 2012-05-23 |
Family
ID=7630548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001557585A Expired - Lifetime JP4936626B2 (ja) | 2000-02-10 | 2001-02-07 | 癌およびその前段階に対する個体の免疫 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20030139334A1 (enExample) |
| EP (1) | EP1253938B1 (enExample) |
| JP (1) | JP4936626B2 (enExample) |
| AT (1) | ATE360439T1 (enExample) |
| AU (1) | AU2001239160A1 (enExample) |
| CA (1) | CA2400007C (enExample) |
| DE (2) | DE10006033B4 (enExample) |
| ES (1) | ES2286108T3 (enExample) |
| WO (1) | WO2001058477A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
| ES2264226T3 (es) | 1997-12-22 | 2006-12-16 | Euro-Celtique S.A. | Forma farmaceutica de dosificacion oral que comprende una combinacion de un agonista opioide y naltrexona. |
| MY135852A (en) | 2003-04-21 | 2008-07-31 | Euro Celtique Sa | Pharmaceutical products |
| RS50817B (sr) | 2004-03-30 | 2010-08-31 | Euro-Celtique S.A. | Dozni oblik otporan na promene koji sadrži adsorbenti i sredstvo sa suprotnim dejstvom |
| US10279018B2 (en) * | 2012-12-03 | 2019-05-07 | Unity Biotechnology, Inc. | Immunogenic compositions for inducing an immune response for elimination of senescent cells |
| CN103293308B (zh) * | 2013-05-24 | 2014-11-26 | 尉军 | 一种检测肿瘤标志物p16抗原表位氨基酸序列及应用 |
| CN111434674B (zh) * | 2018-12-25 | 2024-02-09 | 上海细胞治疗集团有限公司 | 多肽组合物及其在癌症免疫治疗中的用途 |
| CN111848732B (zh) * | 2019-04-30 | 2024-03-12 | 上海细胞治疗集团有限公司 | 多肽组合物及疫苗 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5889169A (en) * | 1991-05-16 | 1999-03-30 | Cold Spring Harbor Laboratory | Cell cycle regulatory protein p16 gene |
| CA2230795A1 (en) * | 1995-09-07 | 1997-03-13 | Khandan Keyomarsi | Cyclin e variants and use thereof |
| US5723313A (en) * | 1995-09-27 | 1998-03-03 | St. Jude Children's Research Hospital | ARF-p19, a novel regulator of the mammalian cell cycle |
| US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
| US6287569B1 (en) * | 1997-04-10 | 2001-09-11 | The Regents Of The University Of California | Vaccines with enhanced intracellular processing |
| PT1003548E (pt) * | 1997-07-10 | 2006-09-29 | Mannkind Corp | Dispositivo para a inducao de uma resposta por ctl |
| AU1099699A (en) * | 1997-10-15 | 1999-05-03 | President And Fellows Of Harvard College | Cell regulatory genes, encoded products, and uses related thereto |
| US6066651A (en) | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
| DE19829473C2 (de) * | 1998-07-01 | 2000-08-10 | Magnus Von Knebel Doeberitz Ch | Verfahren zur frühen Diagnose von Carcinomen |
| BR9916831A (pt) * | 1998-12-17 | 2001-11-20 | Cropdesign Nv | Genes do ciclo celular e seu uso |
-
2000
- 2000-02-10 DE DE10006033A patent/DE10006033B4/de not_active Expired - Lifetime
-
2001
- 2001-02-07 AU AU2001239160A patent/AU2001239160A1/en not_active Abandoned
- 2001-02-07 JP JP2001557585A patent/JP4936626B2/ja not_active Expired - Lifetime
- 2001-02-07 AT AT01913586T patent/ATE360439T1/de active
- 2001-02-07 EP EP01913586A patent/EP1253938B1/de not_active Expired - Lifetime
- 2001-02-07 DE DE50112401T patent/DE50112401D1/de not_active Expired - Lifetime
- 2001-02-07 WO PCT/DE2001/000470 patent/WO2001058477A2/de not_active Ceased
- 2001-02-07 CA CA002400007A patent/CA2400007C/en not_active Expired - Lifetime
- 2001-02-07 US US10/203,206 patent/US20030139334A1/en not_active Abandoned
- 2001-02-07 ES ES01913586T patent/ES2286108T3/es not_active Expired - Lifetime
-
2006
- 2006-05-15 US US11/433,386 patent/US7569538B2/en not_active Expired - Lifetime
-
2009
- 2009-07-09 US US12/500,458 patent/US8946171B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006060314A3 (en) | Generation of replication competent viruses for therapeutic use | |
| IL188113A (en) | Nucleic acid structures encoded with intersectional responses of psma288–297 and prame425–433, or analogs having their intersecting reaction and their use in the preparation of cancer drugs for nucleic acid structures encoded for psma288–297 and prame425–433 cross-reactors Their intersecting response and their use in the preparation of cancer treatment drugs | |
| JP2003503454A5 (enExample) | ||
| NO20032111L (no) | Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter | |
| NO324227B1 (no) | Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer | |
| SE9800836D0 (sv) | New Compounds | |
| JP2005532372A5 (enExample) | ||
| NO20031273L (no) | Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme | |
| HUP0303347A3 (en) | Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis polymorphonucleate and mononucleate cells, process for their preparation and pharmaceutical compositions containing them | |
| NO20053918L (no) | Aminosyrer med affinitet for alfa-2-delta-proteinet. | |
| CY1106056T1 (el) | Παραγωγα 2-αμινο-2-αλκυλ-5-επτενοϊκου και επτυνοϊκου οξεος χρησιμα σαν αναστολεις συνθασης νιτρικου οξειδιου | |
| AU2003246373A8 (en) | Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions | |
| JP2003522157A5 (enExample) | ||
| WO2003039591A3 (de) | Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle | |
| ATE415148T1 (de) | Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid | |
| EP1908839A3 (en) | Virulence genes, proteins, and their use | |
| WO2002060435A8 (fr) | Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer | |
| JP2004500380A5 (enExample) | ||
| WO2005005632A3 (fr) | PETITS ARN INTERFERENTS SPECIFIQUES DES SOUS-UNITES α, α' ET β DE LA PROTEINE KINASE CK2 ET LEURS APPLICATIONS | |
| WO2002055109A3 (en) | Generation and/or reduction of new lung tissue in an affected lung, by modulation of the wnt-pathway | |
| DK1423525T3 (da) | Rekombinant MVA, der kan eksprimere HCV-strukturantigener | |
| CA2400007A1 (en) | Immunization of an individual against carcinoma and the preliminary stages thereof | |
| WO2001054707A3 (de) | Veränderung von oberflächenproteomem durch aminopeptidase-inhibitoren | |
| NO20026198L (no) | Cykliske ketoner, deres fremstilling og deres anvendelse ved syntese av aminosyrer | |
| WO2005102308A3 (en) | Crystalline and amorphous forms of efaproxiral sodium |